CN Patent

CN108925135A — 制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法

Assigned to Neurocrine Biosciences Inc · Expires 2018-11-30 · 7y expired

What this patent protects

本文提供了制备(S)‑(2R,3R,11bR)‑3‑异丁基‑9,10‑二甲氧基‑2,3,4,6,7,11b‑六氢‑1H‑吡啶并[2,1‑a]异喹啉‑2‑基2‑氨基‑3‑甲基丁酸酯二(4‑甲基苯磺酸盐)或其溶剂化物、水合物或多晶型物的方法。

USPTO Abstract

本文提供了制备(S)‑(2R,3R,11bR)‑3‑异丁基‑9,10‑二甲氧基‑2,3,4,6,7,11b‑六氢‑1H‑吡啶并[2,1‑a]异喹啉‑2‑基2‑氨基‑3‑甲基丁酸酯二(4‑甲基苯磺酸盐)或其溶剂化物、水合物或多晶型物的方法。

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: CN108925135A
Jurisdiction: CN
Classification: —
Expires: 2018-11-30
Drug substance claim: No
Drug product claim: No
Assignee: Neurocrine Biosciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.